ARCOXIA Trademark

Trademark Overview

On Tuesday, December 8, 2020, a trademark application was filed for ARCOXIA with the United States Patent and Trademark Office. The USPTO has given the ARCOXIA trademark a serial number of 90367905. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, March 15, 2024. This trademark is owned by Tremeau Pharmaceuticals, Inc.. The ARCOXIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of fever, pain, inflammation and arthritis
arcoxia

General Information

Serial Number90367905
Word MarkARCOXIA
Filing DateTuesday, December 8, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, March 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 6, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of fever, pain, inflammation and arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTremeau Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressConcord, MA 01742
Party NameTremeau Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressConcord, MA 01742

Trademark Events

Event DateEvent Description
Saturday, March 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 15, 2024SOU EXTENSION 4 GRANTED
Friday, March 15, 2024SOU EXTENSION 4 FILED
Friday, March 15, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 12, 2023SOU EXTENSION 3 GRANTED
Tuesday, September 12, 2023SOU EXTENSION 3 FILED
Tuesday, September 12, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 14, 2023SOU EXTENSION 2 GRANTED
Tuesday, March 14, 2023SOU EXTENSION 2 FILED
Tuesday, March 14, 2023SOU TEAS EXTENSION RECEIVED
Saturday, September 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 15, 2022SOU EXTENSION 1 GRANTED
Thursday, September 15, 2022SOU EXTENSION 1 FILED
Thursday, September 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, March 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 1, 2022TTAB RELEASE CASE TO TRADEMARKS
Tuesday, February 1, 2022OPPOSITION TERMINATED NO. 999999
Tuesday, February 1, 2022OPPOSITION DISMISSED NO. 999999
Wednesday, November 3, 2021OPPOSITION INSTITUTED NO. 999999
Tuesday, August 3, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, July 7, 2021ASSIGNED TO EXAMINER
Tuesday, July 6, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 16, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 26, 2021ASSIGNED TO EXAMINER
Tuesday, March 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 16, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, February 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 11, 2020NEW APPLICATION ENTERED

Related Keywords

arcoxia inflammation arthritis pain fever preparations treatment pharmaceutical